VICA (Rafina Innovations) 3-Year EBITDA Growth Rate: 0.00% (As of Mar. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VICA Rafina Innovations Inc VICA
12 GF Score
Price $0.00
View Full Analysis

What is Rafina Innovations 3-Year EBITDA Growth Rate?

Rafina Innovations VICA 12 3-Year EBITDA Growth Rate is 0.00% as of Mar. 2019. GuruFocus rates VICA with a GF Score™ of 12/100.

Rafina Innovations's EBITDA per Share for the three months ended in Mar. 2019 was $-0.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Rafina Innovations  (OTCPK:VICA) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Rafina Innovations 3-Year EBITDA Growth Rate Related Terms

VICA vs RMSL, GTHP, DCTH: 3-Year EBITDA Growth Rate Comparison

For the Medical Devices subindustry, Rafina Innovations's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rafina Innovations 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rafina Innovations's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Rafina Innovations's 3-Year EBITDA Growth Rate falls into.


VICA
12GF Score
Rafina Innovations Inc VICA
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rafina Innovations 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Rafina Innovations (VICA) has a 3-Year EBITDA Growth Rate of 0.00% as of Mar. 2019. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Rafina Innovations and its competitors.
Is Rafina Innovations' 3-Year EBITDA Growth Rate too high?
Rafina Innovations' current 3-Year EBITDA Growth Rate is 0.00%. Overall, Rafina Innovations has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Rafina Innovations' 3-Year EBITDA Growth Rate compare to RMSL and GTHP?
Rafina Innovations' 3-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Medical Devices & Instruments industry. The industry median 3-Year EBITDA Growth Rate is 8.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 8.10, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Rafina Innovations and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 8.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rafina Innovations's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rafina Innovations stock overvalued right now?
Rafina Innovations (VICA) has a current 3-Year EBITDA Growth Rate of 0.00%. The current 3-Year EBITDA Growth Rate is 0.00%. Rafina Innovations' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Rafina Innovations (VICA), the current 3-Year EBITDA Growth Rate is 0.00% as of Mar. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rafina Innovations Business Description

Address 123 West Nye Lane, Suite 129, Carson City, NV, USA, 89706
Rafina Innovations Inc through its subsidiaries is involved in the development of monitoring technologies, set up of rehabilitation centers, development of intellectual property related to everyday fields such as healthcare, sports, automotive and gaming as well as the creation of full-service Prosthetics and Orthotics and Diabetic foot clinics chain in Europe and the Middle East. The firm's main products include Flexisense technology and Rehabilitation clinics etc. It has Clinics and Technology operating segments and derives a majority of its revenues from Clinics segment.
12GF Score

Get the complete analysis for VICA

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price